LONDON – Oxford Nanopore Ltd. raised £25 million (US$41.2 million) in its fourth private round of funding, bringing the amount raised since the company's formation in 2005 to £74 million and enabling it to further advance the development of the GridION platform for the real-time analysis of protein biomarkers. (BioWorld International)

LONDON – Circassia Ltd. claimed the third largest funding round by a European biotech in the past 15 years, raising £60 million (US$98 million) in a fourth round. (BioWorld International)